Therefore, oral 5-ALA with sodium ferrous citrate (SFC) may be effective in AOSD treatment, exerting immune tolerance, and anti-inflammatory effects via induction of HO-1 production. This evidence concerns the gene HMOX1 and adult-onset Still disease.